Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A to Z: Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes; Phase Z

principal contacts

James Lemos (UT Southwestern Medical Center)

Stephen Wiviott (Brigham and Womens' Hospital, Harvard Medical School)

Eugene Braunwald (Brigham and Womens' Hospital, Harvard Medical School)

Yale Mitchel (Merck & Co., Inc)

Andrew Tershakovec (Merck & Co., Inc.)

data custodian

Merck & Co., Inc.

funding

Merck & Co., Inc.

key Publications